5' Capped Labeled RNA for Ribosomal Depletion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for ribosomal RNA depletion in RNA sequencing are inefficient and leave substantial ribosomal and degraded RNA in the mixture, requiring prior knowledge of ribosomal sequences and custom DNA oligonucleotides for hybridization, or using enzymatic degradation that is not comprehensive.

Innovation Solution

A compound represented by Formula (I) is used, where the Base is a purine or pyrimidine, R is a linker, and L is a label such as biotin or fluorescent labels, to convert uncapped RNA into 5' capped labeled RNA through capping enzymes, allowing for enrichment and sequencing of prokaryotic non-ribosomal RNA by immobilization and selective amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If DNA oligonucleotides are used for ribosomal RNA depletion through hybridization, then ribosomal RNA can be removed from the mixture, but custom DNA sequences must be designed and synthesized which increases device complexity and cost

Engineering Contradiction:
Improveribosomal RNA depletion efficiencyVSAvoidcustom DNA oligonucleotide design and synthesis
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention changes the chemical parameter of the depletion probe from DNA oligonucleotide to RNA oligonucleotide with specific modifications (2'-O-methyl and phosphorothioate). This parameter change eliminates the need for custom DNA synthesis while maintaining depletion efficiency, as the modified RNA probes can be purchased as standard products rather than requiring custom design and synthesis.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces expensive custom-synthesized DNA oligonucleotides with commercially available modified RNA oligonucleotides that can be used directly. This substitution uses off-the-shelf reagents rather than custom-made components, reducing both cost and complexity while achieving the same functional outcome of ribosomal RNA depletion.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If enzymatic degradation is used to remove ribosomal RNA, then the process is simpler to perform, but the degradation is inefficient and leaves substantial ribosomal and degraded RNA in the mixture

Engineering Contradiction:
Improvesimplicity of depletion procedureVSAvoidcompleteness of ribosomal RNA removal
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The invention changes the fundamental parameter of the depletion mechanism from enzymatic degradation to hybridization-based capture. Instead of using enzymes that partially degrade RNA, the method uses modified RNA oligonucleotides that hybridize to ribosomal RNA and enable its selective removal through washing, achieving both simplicity and completeness in the depletion process.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If traditional ribosomal RNA depletion methods are used, then ribosomal RNA can be reduced, but degraded RNA remains in the mixture contaminating the sequencing results

Engineering Contradiction:
Improveribosomal RNA reductionVSAvoiddegraded RNA contamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention performs preliminary enrichment of intact RNA molecules before sequencing by using the modified RNA oligonucleotide probes to capture and remove both ribosomal RNA and degraded RNA fragments simultaneously. This preliminary action ensures that only high-quality, intact non-ribosomal RNA remains for sequencing, eliminating degraded RNA contamination from the outset.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively enriches prokaryotic non-ribosomal RNA, reducing ribosomal RNA contamination, enabling more accurate sequencing and identification of transcriptional start sites with single base resolution, and can be applied to complex RNA mixtures without prior sequence knowledge.

Implementation Method 1

combining a preparation comprising uncapped RNA having a 5' diphosphate or 5' triphosphate with a capping enzyme and a labeled modified nucleotide represented by Formula (I) so as to convert the uncapped RNA into 5' capped labeled RNA

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

enriching labeled, capped RNA by immobilizing the labeled capped RNA on an affinity substrate and washing away the unlabeled RNA

Methodology Applied
Scientific EffectAffinity binding: Adhesive

Data Source

PatentEP3077406B1Compositions and methods for capping RNA
Publication Date: 2019.07.10 NEW ENGLAND BIOLABS INC
  • EP3077406B1 patent drawingFigure 1
  • EP3077406B1 patent drawingFigure 2A~2B
  • EP3077406B1 patent drawingFigure 2C~2D

AI summary

Methods and compositions are described for distinguishing target RNA having a 5' diphosphate or triphosphate in a mixture of RNAs. The methods utilized modified labeled nucleotides for capping the 5' end of the RNA. The label on the modified nucleotide is attached to the carbon 3 via the oxygen by replacing the hydrogen ion.